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EMT is a complex process whereby cells lose cell-cell interactions and 
other epithelial properties whilst acquir-
ing a migratory and mesenchymal phe-
notype. EMT is presently recognized as 
an important even for tumor invasion 
and metastasis. Functional E-cadherin 
loss is a hallmark of EMT and required 
for tumor invasion in the majority of car-
cinomas. Transcriptional downregula-
tion is one of the major mechanisms for 
E-cadherin suppression in carcinomas. 
In the last decade several E-cadherin 
repressors, belonging to different tran-
scriptional families, have been identi-
fied that, importantly, also act as potent 
EMT inducers. One of the last addi-
tions to EMT regulators are the class 
I bHLH factors E2-2 (also known as 
TCF4). However, the hierarchical and 
functional interrelations between the 
different EMT inducers are still poorly 
understood. Here, we comment on the 
new and so far unrecognized function 
of E2-2 factors in EMT and discuss on 
the potential interactions among vari-
ous EMT inducers. Emerging evidence 
supporting the participation of TCF4 in 
human malignancies is also discussed. 
Thus, increasing understanding of EMT 
and its regulators is providing meaning-
ful insights into the present knowledge 
on tumor progression.
Helix-loop-helix (HLH) transcriptional 
regulators are broadly present in eukaryotic 
organisms from Saccaromyces cerevisiae to 
human and play important roles in many 
essential developmental processes, regulat-
ing cell growth and differentiation of dis-
tinct cell types. The HLH proteins have 
been classified into seven functional classes 
(I to VII).1 The conserved HLH domain 
mediates homo- or hetero-dimerization. 
In addition, most HLH factors contain a 
stretch of basic amino acid residues adja-
cent to the HLH domain, constituting a 
bHLH motif (Fig. 1A), through which 
they can bind to Ephrussi-box (E box) 
consensus binding site (CANNTG) (Fig. 
1B). In mammals, there are three class I 
genes: E2A, HEB and E2-2, coding for 
several class I bHLH factors also known as 
E-proteins, which are widely expressed, but 
not ubiquitous.1 E-proteins have two con-
served transactivation regions (Fig. 1A), 
AD1 and AD2, of which the N-terminal 
AD1 domain seems to be required both for 
activation and repressor activities in differ-
ent cell types.2-4 E proteins form homodi-
mers o heterodimers with class II family 
member; E proteins dimers usually act 
as transcriptional activators, but can also 
function as repressors depending on the 
bHLH partner and/or the co-regulators 
they are interacting with (Fig. 1B).5-8 The 
transcriptional activity of E-proteins can 
be negatively regulated by class V HLH 
factors, known as Id (Id1-Id4, inhibitor of 
differentiation) proteins, which lack the 
basic DNA binding domain, thus blocking 
promoter interactions of the corresponding 
E protein/Id heterodimers (Fig. 1B).9 The 
E2-2 gene (also known as ITF2, SEF-2 
and TCF4) codes for two highly related 
isoforms, E2-2B and E2-2A (Fig. 1A). Is 
is important to remark here that E2-2/
TCF4 factors should not be confused with 
T-cell factor 4, Tcf4 (recently renamed 
as Tcf7l2) involved in Wnt/β-catenin 
signalling.10 Both E2-2 isoforms differ 
in the N-terminal regions being E2-2A, 
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such as in normal embryonic development 
and wound healing, but also in patholo-
gies like cancer and organ fibrosis.26-29 A 
hallmark of EMT is the functional down-
regulation of the cell-cell adhesion protein 
E-cadherin.26,30 Diminished E-cadherin 
expression has been shown to correlate 
with increased invasiveness and metastatic 
potential28,31,32 and to be the rate limiting 
step in the transition from adenoma to 
carcinoma in pancreatic cancer models.33
Studies from our group and other labo-
ratories have led to the identification of 
several E-cadherin transcriptional repres-
sors and EMT-inducers, such as the zinc 
finger factors Snail1 (Snail) and Snail2 
(Slug), the two-handed zinc finger and 
homeobox proteins SIP1/ZEB2 and δEF1/
ZEB1, and the bHLH regulators E12/E47 
and Twist (reviewed in ref. 32).
Here, we discuss the role of TCF4 prod-
ucts in the maintenance of the mesenchy-
mal phenotype, their interplay with other 
E-cadherin repressors in the regulation 
of EMT and their implication in human 
malignancies.
E2-2 as a New Player in EMT and 
its Relation to Other EMT Inducers
Our recent data have provided evidence 
that E2-2 factors act as potent EMT 
inducers when overexpressed in MDCK 
cells. EMT-mediated by E2-2 holds all 
“essential” markers of EMT, mainly 
downregulation of E-cadherin and other 
epithelial markers (like plakoglobin), 
induction of mesenchymal markers, 
N-cadherin, vimentin and fibronectin and 
acquisition of a motile and highly invasive 
phenotype.25 Although the phenotype 
of MDCK-E2-2 cells is very similar to 
that previously reported for MDCK-E47 
cells, expressing the closely related class I 
bHLH E-47,34 and for MDCK-Snail1 and 
MDCK-Snail2 cells,35,36 important differ-
ences were detected in the biological/tum-
origenic behavior between the different 
cell lines. Thus, E2-2 expression does not 
induce a tumorigenic behavior,25 in con-
trast to the effect of Snail1, Snail2 and E47 
in MDCK cells,34,35,37 whilts MDCK-E2-2 
cells exhibit a stronger invasive behavior 
that MDCK-E47 cells.25,38 In agreement 
with these observations, genomewide 
expression analysis indicated important 
E2-2 factors have been also implicated 
in T-lymphocyte and B-cell differentia-
tion,13,14 in the transition from proliferation 
to differentiation in the mammary gland 
of pregnant mice22 and more recently, as 
specific regulators of Pasmacytoid den-
dritic cell (PDC) development (a dendritic 
cell type specialized in anti-viral response) 
and the PDC-dependent interferon 
response in mice and human.23
In pathologies such as cancer, TCF4 
expression has been found upregulated 
in human cancers with β-catenin defects 
helping to promote growth and/or sur-
vival of cancer cells.24 More recently, we 
have shown that expression of E2-2A/B 
in epithelial cells represses E-cadherin 
expression and drive a full epithelial-to-
mesenchymal transition (EMT).25
EMT is a complex process whereby 
cells lose cell-cell interactions and other 
epithelial properties whilst acquiring a 
migratory and mesenchymal phenotype.26 
EMT occurs in different biological situa-
tions involving cell migration or invasion, 
the shorter isoform, devoid of the AD1 
domain (Fig. 1A)2,11 and has been described 
as a transcriptional regulator with dimin-
ished or absent repressor capacity.2,12
E2-2 is expressed in different tissues 
such as brain, muscle, liver, lung, testicle, 
trophoblasts and mammary gland.13,14 
Homozygous TCF4 deletion in mice lead 
to early lethality of unknown reason,15 
suggesting an essential role for E2-2 fac-
tors in development. In addition, genetic 
studies have recently demonstrated that 
loss of one copy of TCF4 in human causes 
the Pitt-Hopkins syndrome,16-18 a neu-
rodevelopment disease characterized by 
mental retardation, seizures and hyper-
ventilation,19 supporting an essential role 
for E2-2 factors in human nervous system 
development. In fact, it has been observed 
that E2-2 forms functional heterodim-
ers with the bHLH factors HASH-1 and 
MATH1, involved in development of spe-
cific parts of the central and peripheral 
nerves.20,21 Nevertheless, the specific cellu-
lar roles of E2-2 factors remain elusive.
Figure 1. Class i HLH transcriptional factors. (a) Diagrammatic representation of the main func-
tional domains of the e2-2a/B isoforms and e47/e12 factors; aD1, aD2: activation domain; bHLH: 
basic Helix-Loop-Helix domain (Dna binding domain). (B) Depiction of the binding of active 
heterodimer (class i bHLH/class ii bHLH) (left) and inactive heterodimer (class i bHLH/class V HLH/
id) to the e-box (CanntG) element.
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Further evidence for a cross-talking 
regulation among Snail and bHLH fac-
tors is provided by promoter analysis. Our 
initial studies indicate that Snail1 and 
Snail2 upregulate E2-2A promoter by still 
undefined mechanisms, while E2-2 factors 
downregulate human Snail1 and Snail2 
promoters as well as the E2-2A promoter 
(Sobrado, Cano A, et al. unpublished data), 
suggesting a delicate and intricate balance 
in the regulation of various EMT inducers 
(Fig. 2B). In contrast, E47 is apparently 
not able to regulate the E2-2A promoter, 
and E2-2 factors have a very faint effect 
on the E2A promoter. Interestingly, Snail1 
has also been reported to downregulate its 
own promoter in different epithelial cell 
systems,45 further reinforcing the fine-tune 
regulation of various EMT regulators.
E2-2 in Human Malignancies
The above discussed data support a role 
for E2-2 factors in EMT regulation, 
and suggest their involvement in human 
malignancies. Scarce data on expression of 
E2-2/TCF4 in human tumors are already 
available. E2-2 was detected as a down-
stream target of β-catenin/Lef in human 
cancers with β-catenin defects.24 A recent 
report has detected E2-2/TCF4 as one 
of the four major upregulated genes in 
variant bone metastatic cells established 
from a human lung carcinoma cell line.46 
Importantly, in this later study TCF4 was 
confirmed as one of three factors suffi-
cient to confer bone metastatic ability to 
ZEB1 and Twist1 are also potent 
inducers of EMT,41,42 although the hierar-
chical relation between the different fac-
tors is still unclear. In addition, whether 
Twist1 is a direct repressor of E-cadherin 
has not been so far demonstrated.29,41 In 
Drosophila, Twist has been shown to be 
upstream of Snail43 and a recent report 
also supports a similar epistatic relation 
beween Twist1 and Snail1 in rat kidney 
cells;44 however, this epistatic relation 
has not been so far demonstrated in other 
systems. Indeed, our own results indi-
cate that Twist1 is downstream of Snail1/
Snail2, E47 and E2-2 factors,25,37 suggest-
ing that the epistatic relation between 
Twist1 and other EMT inducers might be 
context dependent. The present evidence 
lead us to propose a model for the hier-
archical relation between different EMT 
inducers, initially described in Peinado 
et al.32 and further extended in the scheme 
presented Figure 2A. The diagram shows 
the different interrelations between Snail 
and bHLH factors derived mainly from 
data obtained from the MDCK model 
system at mRNA level. Snail1, Snail2 and 
E47 upregulate E2-2 expression; E47 and 
Snail2 upregulate each other, while Snail1, 
E47 and E2-2 upregulate ZEB1 expres-
sion25,37,40 (Cubillo, Cano A, et al. unpub-
lished data). On the other hand, Twist1 
is upregulated by E47 and E2-2 and to 
a lower extent by Snail1 and Snail2.25,37 
Whether Twist1 can also induce Snai1 
factors in MCDK cells, as described in rat 
kidney cells,44 remains to be explored.
differences in the gene expression profile 
induced by both types of E-proteins and 
Snail factors.25,37 Interestingly, the gene 
profiling studies also showed that E2-2 is 
downstream of Snail1, Snail2 and E47 in 
the MDCK cell system,37 and further con-
firmed by RT-PCR analysis.25 On the other 
hand, although a complete suppression of 
E-cadherin promoter transcriptional activ-
ity is found in MDCK-E2-2 cells, this 
appears to be independent of E-boxes in 
the proximal promoter. Indeed, E2-2B 
is not bound to endogenous E-cadherin 
promoter, in contrast to Snail1 or E47 fac-
tors25 (Cubillo, Cano A, et al. manuscript 
in preparation), indicating that, at least, 
E2-2B is an indirect E-cadherin repressor.
Taken together, the above data indicate 
that different EMT inducers, belonging 
to E proteins and Snail factors, can play 
differential roles in the regulation of EMT 
and, more importantly, in the biological 
consequences of the process. Furthermore, 
they suggest the existence of epistatic 
and/or mechanistic links between dif-
ferent EMT regulators.32 In a search for 
the specific function of E2-2 factors and 
their relation to other EMT regulators, 
knockdown studies of TCF4 were per-
formed in MDCK cells stably expressing 
Snail1, E47 or E2-2 factors. Surprisingly, 
specific silencing (up to 70–80%) of 
ectopic E2-2 in MDCK-E2-2 cells or 
endogenous E2-2 factors overexpressed in 
MDCK-Snail1 and MDCK-E47 cells did 
not led to upregulation of E-cadherin or 
to restoration of an epithelial-like pheno-
type,25 indicating that TCF4 expression 
is dispensable for the maintenance of the 
mesenchymal phenotype once EMT has 
been established by Snail1, E47 or E2-2 
factors, at least in the MCDK system. 
This contrast to the effect of Snail1 or 
E47 knockdown in MDCK-Snail1,39 or 
MDCK-E47 cells (Cubillo, Cano A, et 
al. manuscript in preparation) which lead 
to a complete reversion of E-cadherin 
expression and the epithelial phenotype. 
This also raises the question of whether 
other downstream targets could be 
involved in the maintenance of the mes-
enchymal phenotype in E2-2 expressing 
cells. Interestingly, ZEB1 and Twist1 fac-
tors are found downstream of Snail1, E47 
and E2-2 in MDCK cells and other cell 
systems.25,37,40
Figure 2. Diagrammatic representation of the proposed hierarchical relations between different 
emt inducers. (a) model based in the analysis of gene expression profiles and rt-PCr in mDCK 
cells stably expressing Snail1, Snail2, e47 and e2-2 (solid arrows) (refs. 25 and 37); broken arrows 
indicate relations established at the mrna level in other cell systems (refs. 40 and 46). (B) model 
based in the analysis of the activity of the human Snail1, Snail2 and E2-2A promoters in mDCK cells 
after transient expression of Snail1, Snail2 or e2-2a factors.
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well as a direct association with Snail2 
expression.28 Together, these observa-
tions support the participation of the 
EMT inducers, E2-2 and ZEB1 factors, 
in human malignancies and support the 
hierarchical relation between both fac-
tors proposed from studies on cell sys-
tems (Fig. 2A).
Further functional studies on dedicated 
cell model systems and development of 
transgenic cancer mouse models in which 
different EMT inducers are modified will 
be instrumental for establishing the func-
tional role of E2-2 and other EMT factors 
and their interrelations in tumor progres-
sion. We also envision that these studies 
will provide new avenues and novel tar-
gets for anti-tumor and anti-metastatic 
strategies.
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parental lung carcinoma cells,46 support-
ing an important role for E2-2 factors in 
bone metastasis. Whether this situation 
can be extended to other carcinoma and 
metastatic cell lines and tumors remains 
to be explored. More importantly, analy-
sis of E2-2 proteins in human tumors 
(primary and metastasis lessions) should 
be performed once reliable antibodies are 
available. Meanwhile, we have interro-
gated public database of gene expression 
in lung squamous cell carcinomas47 for 
TCF4 mRNA expression and its poten-
tial relation with other EMT regulators. 
As shown in Figure 3, a statistical sig-
nificant association was found between 
TCF4 expression and decreased over-
all survival. These data, together with 
those reported in lung carcinoma cells,46 
support an important and so far unrec-
ognized role for E2-2 factors in lung 
cancer. Interestingly, a previous similar 
survey of ZEB1 (TCF8) expression in 
public databases and correlation with 
clinico-pathological features showed 
an strong association of TCF8 expres-
sion with metastasis and low overall 
survival of N0 breast carcinomas, as 
Figure 3. Kaplan-meier analysis of TCF4/E2-2 expression in lung squamous cell carcino-
mas from public microarray dataset (n = 51; ref. 47). High (black) and low (grey) expres-
sion values of tCF4 mrna were obtained from the average expression ratio. p value was 
derived from log-rank tests.
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